Oral low dose butyrate compositions

摘要

This invention relates to orally available compositions which deliver an amount of butyrate or a butyrate analogue effective to ameliorate beta-hemoglobinopathies, such as beta-thalassemia and sickle cell anemia, cystic fibrosis, cancer and other diseases which are known to be treatable with butyrate. The invention also relates to methods of treating these diseases with such low dose oral compositions.